Novel role of transient receptor potential vanilloid 2 in the regulation of cardiac performance

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 306, Issue 4, 2014, Pages

  Rubinstein, Jack ^a   Lasko, Valerie M ^a   Koch, Sheryl E ^a   Singh, Vivek P ^a   Carreira, Vinicius ^a   Robbins, Nathan ^a   Patel, Amit R ^a   Jiang, Min ^a   Bidwell, Philip ^a   Kranias, Evangelia G ^a   Jones, W Keith ^a   Lorenz, John N ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Blood flow; Blood pressure; Calcium; Cardiac myocytes; Contractility; Hemodynamics; Ion channels; Probenecid; Vascular resistance

Indexed keywords

BLOOD FLOW; BLOOD PRESSURE; CALCIUM; CARDIAC MYOCYTES; CONTRACTILITY; HEMODYNAMICS; ION CHANNELS; PROBENECID; VASCULAR RESISTANCE;

ANIMALS; CALCIUM CHANNELS; HEART; HEMODYNAMICS; MICE; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCARDIUM; MYOCYTES, CARDIAC; PROBENECID; SARCOPLASMIC RETICULUM; TRPV CATION CHANNELS; URICOSURIC AGENTS;

EID: 84894049931     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00854.2013     Document Type: Article

References (25)

1. Bang S, Kim KY, Yoo S, Lee SH, Hwang SW. Transient receptor potential V2 expressed in sensory neurons is activated by probenecid. Neurosci Lett 425: 120-125, 2007.
2. Caterina MJ, Rosen TA, Tominaga M, Brake AJ, Julius D. A capsaicin-receptor homologue with a high threshold for noxious heat. Nature 398: 436-441, 1999.
3. González-Cobos JC, Zhang X, Motiani RK, Harmon KE, Trebak M. TRPs to cardiovascular disease. In: TRP Channels in Drug Discovery. Totowa, NJ: Humana, 2012, p. 3-40.
4. Gutman AB, Yu TF. Benemid (p-[di-n-propylsulfamyl]-benzoic acid) as uricosuric agent in chronic gouty arthritis. Trans Assoc Am Physicians 64: 279-288, 1951.
5. Inoue R, Jensen LJ, Shi J, Morita H, Nishida M, Honda A, Ito Y. Transient receptor potential channels in cardiovascular function and disease. Circ Res 99: 119-131, 2006.
6. 2+-permeable growth factor-regulated channel. J Cell Biol 161: 957-967, 2003.
7. Kamouh A, Francis GS. Contemporary management and research directions in advanced heart failure: where are we going? Congest Heart Fail 17: 241-247, 2011.
8. Kanzaki M, Zhang YQ, Mashima H, Li L, Shibata H, Kojima I. Translocation of a calcium-permeable cation channel induced by insulinlike growth factor-I. Nat Cell Biol 1: 165-170, 1999.
9. Koch SE, Gao X, Haar L, Jiang M, Lasko VM, Robbins N, Cai W, Brokamp C, Varma P, Tranter M, Liu Y, Ren X, Lorenz JN, Wang HS, Jones WK, Rubinstein J. Probenecid: novel use as a non-injurious positive inotrope acting via cardiac TRPV2 stimulation. J Mol Cell Cardiol 53: 134-144, 2012.
10. Koch SE, Tranter M, Robbins N, Luther K, Singh U, Jiang M, Ren X, Tee T, Smith L, Varma P, Jones WK, Rubinstein J. Probenecid as a noninjurious positive inotrope in an ischemic heart disease murine model. J Cardiovasc Pharmacol Ther 18: 280-289, 2013.
11. Li L, Chu G, Kranias EG, Bers DM. Cardiac myocyte calcium transport in phospholamban knockout mouse: relaxation and endogenous CaMKII effects. Am J Physiol Heart Circ Physiol 274: H1335-H1347, 1998.
12. +-ATPase subunit. Am J Physiol Heart Circ Physiol 295: H273-H280, 2008.
13. Muraki K, Iwata Y, Katanosaka Y, Ito T, Ohya S, Shigekawa M, Imaizumi Y. TRPV2 is a component of osmotically sensitive cation channels in murine aortic myocytes. Circ Res 93: 829-838, 2003.
14. Nedungadi TP, Dutta M, Bathina CS, Caterina MJ, Cunningham JT. Expression and distribution of TRPV2 in rat brain. Exp Neurol 237: 223-237, 2012.
15. O'Connell TD, Rodrigo MC, Simpson PC. Isolation and culture of adult mouse cardiac myocytes. Methods Mol Biol 357: 271-296, 2007.
16. 2+-cycling and severe pathology under pressure-overload stress. Basic Res Cardiol 108: 344, 2013.
17. Park U, Vastani N, Guan Y, Raja SN, Koltzenburg M, Caterina MJ. TRP vanilloid 2 knock-out mice are susceptible to perinatal lethality but display normal thermal and mechanical nociception. J Neurosci 31: 11425-11436, 2011.
18. Pedersen SF, Owsianik G, Nilius B. TRP channels: an overview. Cell Calcium 38: 233-252, 2005.
19. Robbins N, Koch SE, Rubinstein J. Targeting TRPV1 and TRPV2 for potential therapeutic interventions in cardiovascular disease. Transl Res 161: 469-476, 2013.
20. Robbins N, Koch SE, Tranter M, Rubinstein J. The history and future of probenecid. Cardiovasc Toxicol 12: 1-9, 2012.
21. Selen A, Amidon GL, Welling PG. Pharmacokinetics of probenecid following oral doses to human volunteers. J Pharm Sci 71: 1238-1242, 1982.
22. Sharif-Naeini R, Ciura S, Zhang Z, Bourque CW. Contribution of TRPV channels to osmosensory transduction, thirst, and vasopressin release. Kidney Int 73: 811-815, 2008.
23. Stokes AJ, Shimoda LM, Koblan-Huberson M, Adra CN, Turner H. A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells. J Exp Med 200: 137-147, 2004.
24. Woodbury CJ, Zwick M, Wang S, Lawson JJ, Caterina MJ, Koltzenburg M, Albers KM, Koerber HR, Davis BM. Nociceptors lacking TRPV1 and TRPV2 have normal heat responses. J Neurosci 24: 6410-6415, 2004.
25. Yang XR, Lin MJ, McIntosh LS, Sham JS. Functional expression of transient receptor potential melastatin-and vanilloid-related channels in pulmonary arterial and aortic smooth muscle. Am J Physiol Lung Cell Mol Physiol 290: L1267-L1276, 2006.